Atamosa, Jenalien B.
HRN: 27-76-67 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2025
CEFUROXIME 500MG (TAB)
09/09/2025
09/15/2025
ORAL
500mg
Q12
RMLE
Checking Initial Appropriateness